Indirect analysis of first-line therapy for advanced non-small-cell lung cancer with activating mutations in a Japanese population.
Future Oncol. 2021 Jan;17(1):103-115. doi: 10.2217/fon-2020-0651. Epub 2020 Sep 22.
Future Oncol. 2021.
PMID: 32959703
Free article.